Atlas Trials

Caffeic Acid Tablets as a Second-line Therapy for ITP

Clinical trial NCT02351622 · COMPLETED

Trial details

NCT number
NCT02351622
Sponsor
Shandong University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2012-09-01
Primary completion
2013-12-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.